logo-loader
Fulham Shore PLC

The Fulham Shore strikes a bullish tone as diners tuck into sour dough pizzas

The Franco Manca/Real Greek owner is now considering a dividend as trading this year has started well.

pizza
Sour dough pizzas have them queuing up says Fulham Shore

Innovations such as a vegan Greek menu kept sales and profits rising at The Fulham Shore PLC (LON:FUL) over the past year.

The restaurateur scaled back its opening programme at the start of the year but still opened a net three Franco Mancas to make a portfolio of  63 outlets comprising 47 pizza outlets and 16 The Real Greeks.

Fulham Shore expects to have 68 outlets in total by the end of the current financial year.

David Page, chairman, said that fewer openings had improved its cash position and it was now considering a dividend as trading this year has started well.

“Against the background of the capital lavished on the UK restaurant sector over the last five years, we at Fulham Shore have improved Headline EBITDA in every reporting period since our admission to AIM in 2014.

“We are pleased to report the demand for both of our businesses continues to grow.

"We will continue to open new restaurants in carefully chosen locations, conscious of the property pitfalls that others have fallen into.”

Sales in the year to March just ended rose by 17% to £64mln, with headline profits 5% better at £7.8mln.

Pre-tax profits jumped to £1.4mln from a loss of £100,000 as impairment and share-based costs fell.

Shares rose 6% to 12.25p.

Quick facts: Fulham Shore PLC

Price: £0.11

Market: AIM
Market Cap: £64.53 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan PLC targeting 'value creation and rapid scale-up'

Proactive Research analyst Emma Ulker discusses the opportunity with Open Orphan PLC (LON:ORPH). She says the firm's targeting value creation and rapid scale-up via acquisitions in the orphan and rare drugs market - a space which is growing at around 11% a year. Ulker adds they're looking...

8 hours, 8 minutes ago

2 min read